Skip to main content
Clinical Trials/NCT04875221
NCT04875221
Withdrawn
Not Applicable

Mechanisms of Network-based Real-time fMRI Neurofeedback in Patients With Posttraumatic Stress Disorder

Lawson Health Research Institute1 site in 1 countryOctober 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PTSD
Sponsor
Lawson Health Research Institute
Locations
1
Primary Endpoint
Changes in emotional experience over neurofeedback training (RSDI scale)
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

This project will examine the use of real-time fMRI (rt-fMRI) neurofeedback in the regulation of neural networks underlying symptoms experienced by individuals with posttraumatic stress disorder (PTSD). Investigators will use rt-fMRI neurofeedback in order to facilitate emotion regulation during symptom induction, and examine individual differences that influence regulation capacities.

Detailed Description

The purpose of this study is to examine the mechanisms of real-time fMRI (rt-fMRI) neurofeedback as a method by which to regulate functional brain connections underlying symptoms/emotions experienced by individuals with PTSD. The aim of this study is to evaluate further the suitability of state-of-the-art fMRI as a non-invasive therapeutic tool among individuals burdened by PTSD, in order to inform future clinical trials of neurofeedback aiming to reduce symptoms of PTSD. This will be achieved by using rt-fMRI and neurofeedback of brain signals, in order to teach individuals with PTSD to self-regulate the neural networks that are associated with their symptoms. Investigators will examine the mechanisms of self-regulating neural networks using real-time neuroimaging and feedback to these brain signals. Neurofeedback is a form of brain training that allows individuals to improve their health by learning to control signals from their own body. This study will employ a 2 (PTSD group vs. healthy control group) by 2 (arm; experimental vs. sham-control) design. This study involves an assessment which will include clinical interviews and a fMRI (functional magnetic resonance imaging) scan. The fMRI scan will involve trauma-word exposure during neurofeedback task runs. During the presentation of the words in the fMRI scanner, participants in the experimental arm will be able to view a feedback display that informs them of the strength of connectivity between the target regions. Participants in the sham-control arm will receive yoked sham neurofeedback signal (or fake signal), corresponding to a replayed feedback signal from a successful participant in the experimental group in order to ensure similar motivational states and following standard methods. In both arms, feedback signals will be relayed back to the participant in the scanner through visualization software as a thermometer that increases or decreases as the extent to which the target model dominates.

Registry
clinicaltrials.gov
Start Date
October 1, 2023
End Date
September 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ruth Lanius

Principal Investigator

Lawson Health Research Institute

Eligibility Criteria

Inclusion Criteria

  • PTSD Group:
  • English speaking
  • age: 18-65
  • meets diagnostic criteria for PTSD (as determined by study assessment)
  • Control Group:
  • English speaking
  • age: 18-65

Exclusion Criteria

  • All participants:
  • Individuals with any implants, conditions, etc. that do not comply with 3-Tesla fMRI research safety standards (e.g., certain implants, pregnancy)
  • history of neurological disorder
  • history of any pervasive developmental disorder
  • history of significant head injury/lengthy loss of consciousness (e.g., a Glasgow Coma Scale Score \< 15 at the time of incident assessed retrospectively by participant)
  • significant untreated medical illness
  • alcohol/substance abuse or dependence within the last 3 months
  • PTSD Group:
  • history of bipolar disorder
  • history of psychosis

Outcomes

Primary Outcomes

Changes in emotional experience over neurofeedback training (RSDI scale)

Time Frame: 1-week

The Response to Script Driven Imagery (RSDI) Scale will assess changes in symptoms after each neurofeedback run in the scanner (3 training runs), in line with previous neurofeedback studies. Investigators will evaluate changes in emotional experience during neurofeedback treatment and at 1-week follow-up, using the RSDI scale. The RSDI has a minimum value of 0 and maximum value of 66 (higher scores indicate more severe symptoms/emotional distress).

Changes in functional magnetic resonance imaging (fMRI) neural connectivity/activation

Time Frame: 1hour

Investigators will evaluate changes in fMRI neural connectivity and activation as a function of neurofeedback treatment. Specifically, investigators will evaluate changes in fMRI neural connectivity/activity among brain areas included in the neurofeedback target network (which includes areas within the default mode, salience, and central executive networks).

Secondary Outcomes

  • Changes in PTSD symptoms over neurofeedback training (PCL-5)(1-week)

Study Sites (1)

Loading locations...

Similar Trials